Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy

J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, E. Růžička,

. 2015 ; 262 (4) : 992-1001. [pub] 20150217

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT12288 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online Full text

NLK ProQuest Central from 1997-04-01 to 2017-12-31
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-04-01 to 2017-12-31

Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010550
003      
CZ-PrNML
005      
20181018142212.0
007      
ta
008      
160408s2015 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00415-015-7671-1 $2 doi
024    7_
$a 10.1007/s00415-015-7671-1 $2 doi
035    __
$a (PubMed)25683763
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Rusz, Jan $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Technická 2, 160 00, Prague 6, Czech Republic, rusz.mz@gmail.com. $7 xx0093732
245    10
$a Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy / $c J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, E. Růžička,
520    9_
$a Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multisystémová atrofie $x komplikace $7 D019578
650    _2
$a Parkinsonova nemoc $x komplikace $7 D010300
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a poruchy řeči $x klasifikace $x diagnóza $x etiologie $7 D013064
650    _2
$a progresivní supranukleární obrna $x komplikace $7 D013494
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bonnet, Cecilia $7 xx0208282
700    1_
$a Klempíř, Jiří $7 xx0081730
700    1_
$a Tykalová, Tereza $7 _AN089882
700    1_
$a Baborová, Eva $7 xx0192811
700    1_
$a Novotný, Michal $7 ctu2018985794
700    1_
$a Rulseh, Aaron Michael $7 xx0243723
700    1_
$a Růžička, Evžen, $d 1957- $7 jo20000074065
773    0_
$w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 262, č. 4 (2015), s. 992-1001
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25683763 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20181018142712 $b ABA008
999    __
$a ok $b bmc $g 1113979 $s 934918
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 262 $c 4 $d 992-1001 $e 20150217 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
GRA    __
$a NT12288 $p MZ0
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...